Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
SynKinase
BMS-599626
CHF 0.00
In stock
SYN-1142-M0011 mgCHF 149.00
SYN-1142-M0055 mgCHF 234.00
SYN-1142-M01010 mgCHF 390.00
SYN-1142-M05050 mgCHF 1'235.00
SYN-1142-M100100 mgINQ
Product Details | |
---|---|
Synonyms | AC-480; BMS599626 |
Product Type | Chemical |
Properties | |
Formula | C27H27FN8O3 |
MW | 530.6 |
CAS | 714971-09-2 |
Purity Chemicals | ≥95% |
Appearance | Solid. |
Solubility | Soluble in DMSO or ethanol. |
Declaration | Manufactured by SynKinase. |
Other Product Data |
Target: EGFR - HER2 | Kinase Group: RTK | Substrate: Tyrosine Click here for Original Manufacturer Product Datasheet Our product description may differ slightly from the original manufacturers product datasheet. |
InChi Key | LUJZZYWHBDHDQX-QFIPXVFZSA-N |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
BMS-599626 is an orally bioavailable, highly selective and potent pan-HER kinase inhibitor. It inhibits HER1 and HER2 with IC(50) values of 20 and 30nM, respectively.
Product References
- Preclinical antitumor activity of BMS-599626, a pan-HER kinase inhibitor that inhibits HER1/HER2 homodimer and heterodimer signaling: T.W. Wong, et al.; Clin. Cancer Res. 12, 6186 (2006)